Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06289166
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-02-23
Brief Title:
Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
Sponsor:
Staidson Beijing Biopharmaceuticals Co Ltd
Organization:
Staidson Beijing Biopharmaceuticals Co Ltd
Study Overview
Official Title:
A Multi-center Open-label Phase Ⅱb Trial to Evaluate the Safety and Efficacy of STSP-0601 for Injection in Patients With Hemophilia With Inhibitor
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None